Curcumin inhibition of bleomycin-induced changes in lung collagen synthesis, deposition and assembly

Mol Biol Rep. 2021 Dec;48(12):7775-7785. doi: 10.1007/s11033-021-06790-3. Epub 2021 Oct 13.

Abstract

Background: Idiopathic pulmonary fibrosis is characterized by progressive lung tissue remodeling and disproportionate deposition of collagenous proteins with limited therapeutic interventions. The purpose of this study was to determine whether curcumin inhibits bleomycin (BLM)-induced increases in synthesis, degradation and cross-linking of lung collagen in rats.

Methods and results: Following a single intratracheal instillation of BLM to rats (0.75 U/100 g, sacrificed 3, 5, 7, 14 and 28 days post-BLM), lung collagen synthesis (determined by incorporation of 3H-proline) and deposition (determined by lung hydroxyproline content) progressively increased at days 7, 14 and 28 post-BLM injection. Lung lavage fluid hydroxyproline and collagenase levels (a measure of collagen turnover) were increased in BLM rats compared with control groups. In addition, BLM instillation resulted in increased concentrations of collagenase and collagenolytic cathepsin in the lungs. Furthermore, increased cross-linking (as determined by aldehyde content of acid soluble collagen), and decreased susceptibility of fibrotic lung insoluble collagen to denaturing agents occurred in BLM-injured lungs. Significant increases in alveolar macrophage (AM) release of transforming growth factor-β1 (TGF-β1) were noted at various time points (days 3, 5, 7, 14 and 28 post-BLM) during the development and progression of lung fibrosis in rats. Curcumin treatment to BLM rats (300 mg/kg 10 days before and daily thereafter throughout the experimental time period) was associated with marked reductions in lung collagen synthesis and deposition, BALF and lung collagenase activity, BALF hydroxyproline content and lung collagenolytic levels. Additionally, reduced levels of collagen cross-linking and enhanced susceptibility of insoluble lung collagen to denaturing agents were observed in curcumin-treated BLM rats. Finally, curcumin inhibited BLM-induced increases in AM production of TGF-β1.

Conclusions: Our data demonstrate for the first time that curcumin prevents fibrotic deposits by modulating collagen turnover, assembly and deposition in BLM-instilled rat lungs, and that curcumin treatment protects against BLM activation of macrophages by suppressing the release of TGF-β1.

Keywords: Bleomycin; Collagen; Curcumin; Extracellular matrix; Lung fibrosis.

MeSH terms

  • Animals
  • Bleomycin / adverse effects
  • Bleomycin / pharmacology
  • Bronchoalveolar Lavage Fluid
  • Collagen / biosynthesis*
  • Collagen / drug effects*
  • Collagen / metabolism
  • Curcumin / metabolism
  • Curcumin / pharmacology*
  • Extracellular Matrix / metabolism
  • Idiopathic Pulmonary Fibrosis / chemically induced
  • Idiopathic Pulmonary Fibrosis / drug therapy
  • Idiopathic Pulmonary Fibrosis / physiopathology
  • Lung / drug effects
  • Lung / pathology
  • Macrophages, Alveolar / metabolism
  • Male
  • Rats
  • Rats, Wistar
  • Transforming Growth Factor beta / metabolism

Substances

  • Transforming Growth Factor beta
  • Bleomycin
  • Collagen
  • Curcumin